105 exhibitors have been recruited for the Public Health and Epidemic Prevention Exhibition of the Service Trade Fair
At least 105 companies will appear at the Public Health and Epidemic Prevention Exhibition of the Service Trade Fair
The new crown inactivated vaccine developed by Chinese companies, the equipment that can complete the rapid nucleic acid test of the new crown virus in 30 minutes, the Beijing hospital preparations and the new crown prevention prescription... The reporter learned from the Beijing Municipal Health Commission yesterday that at this year’s service trade conference, At least 105 companies will be exhibiting at the Public Health and Epidemic Prevention Exhibition, among which Chinese companies will showcase strong products in the fight against the epidemic.
Aspect 1
World epidemic prevention cooperation and China's anti-epidemic story have become highlights
In accordance with the arrangements of the Organizing Committee of the 2020 International Trade Fair in Services, the Beijing Municipal Health Commission took the lead in hosting the exhibition on the public health and epidemic prevention of the Trade Fair.
According to Zheng Jinpu, the second-level inspector of the Beijing Municipal Health Commission, 105 exhibitors have been recruited to the public health and epidemic prevention exhibition area, including 60 offline exhibitors. Among all participating companies, 13 are Fortune 500 companies and 17 are industry leaders, covering 8 countries and 13 provinces and cities in my country.
With the theme of "Health and Safety for All", the exhibition area features "World Anti-epidemic Cooperation", "China Anti-epidemic Story", and "Chinese Medicine Anti-epidemic". The role is to use early prevention, early detection, early management, and early treatment as the display context to promote and display outstanding medical and health service solutions and bright products of enterprises in the fields of medicine, equipment, and information technology.
At the same time, during the Service Trade Fair, the public health forum co-sponsored by the Beijing Municipal Health Commission and the International Exchange and Cooperation Center of the National Health Commission will focus on the theme of "gathering the world’s wisdom in epidemic prevention and fighting against global disease threats." , Openness, cooperation, government, industry, university, research, and international partners to discuss global health cooperation under the new crown epidemic, and strive to create a platform for international epidemic prevention experience exchange and sharing.
Aspect 2
New crown vaccine, rapid nucleic acid test equipment, etc. will be unveiled
This event invited representatives of some exhibiting companies to focus on the role of companies in scientific research and technology leadership in the prevention and control of the new crown epidemic, and their contribution to corporate wisdom.
Zhang Yuntao, vice president of China National Biotechnology Co., Ltd., introduced that in this exhibition, products such as new crown virus nucleic acid molecular detection reagents and new crown inactivated vaccines will be displayed in the form of online and offline synchronization. At the same time, in the face of the threat of the new crown pneumonia epidemic, China Biotech will actively develop new crown virus vaccines. After the new crown vaccine production workshops of the two subordinate research institutes are put into use, it will be able to guarantee the total annual production capacity of new crown vaccines to 220 million doses.
Yin Weidong, Chairman of Kexing Holding Biotechnology Co., Ltd., introduced that during the exhibition, the new crown inactivated vaccine Kerlaifu TM will be displayed, China’s first inactivated hepatitis A vaccine Haierlaifu R that has passed the WHO pre-certification, category 1 preventive biological products New drug EV71 vaccine Yierlaifu R and other products. The inactivated new crown vaccine developed by Kexing is starting phase III clinical trials in many countries around the world.
Kayudi Biotechnology (Beijing) Co., Ltd. will bring its "Flash20 Novel Coronavirus Nucleic Acid Quick Detection System" to the public health and epidemic prevention special exhibition area. The flash test system has significant advantages. The detection time is 30 minutes and the sample addition time is 1 minute. The system is not only suitable for hospital POCT scenes and primary medical institutions, but also can effectively carry out on-site emergency detection. Founder and CEO Li Xiang said that Kayudi Bio is a domestically developed high-tech innovation enterprise that has been deeply involved in the fields of biosafety and disease control and epidemic control for 10 years. It is equipped with instruments, reagents, system platforms and artificial intelligence big data and other cross-field joint development. Ability.
Aspect 3
Chinese companies will exhibit new crown Chinese medicine preventive prescriptions
Luo Zenggang, deputy director of the Beijing Administration of Traditional Chinese Medicine, introduced the relevant situation of the exhibition area of the Chinese medicine sector.
During the exhibition, the Beijing Municipal Administration of Traditional Chinese Medicine will hold three sessions: "International Think Tank Forum on Traditional Chinese Medicine and Health Industry", "2020 Beijing Forum on International Development of Traditional Chinese Medicine" and "The Launching Ceremony of the Theme Day of Traditional Chinese Medicine and the Fifth Overseas Chinese and Overseas Chinese Medicine Conference" Activities, and the establishment of a cultural dissemination and international industry consortium for the hometown of famous Chinese medicine doctors, and the release of the "Joint Action Proposal for Making Chinese Medicine Go Global" to help the Chinese medicine service trade flourish.
More than 40 Chinese medicine companies and institutions including China Academy of Chinese Medical Sciences, Beijing University of Chinese Medicine, Tongrentang Group, Yiling Pharmaceutical, etc. will participate in the exhibition. The exhibition will also focus on Chinese medicine culture and education, technological innovation, interactive experience and anti-epidemic results. The combination of online and offline displays the industry’s advanced achievements and technologies.
Among them, Laikang Technology (Beijing) Co., Ltd., Beijing Shenxinkang Technology Co., Ltd., Zhongke Shangyi Health Technology (Beijing) Co., Ltd., Beijing Boao Jingxin Technology Co., Ltd. and other companies will display pulse diagnosis instruments and tongue images. Chinese medicine intelligent equipment including medical instruments, visual diagnosis instruments, human-machine interactive intelligent Chinese medicine diagnosis and treatment platform, and intelligent meridian guidance platform; Chinese medicine teaching, such as China Academy of Chinese Medical Sciences, Beijing University of Chinese Medicine, Beijing Chinese Medicine Hospital, Guanganmen Hospital, etc. Medical institutions will focus on displaying the status of international cooperation in traditional Chinese medicine and their achievements during the anti-epidemic period, including the international teleconsultation platform, the World Health Organization's cooperation projects in China, the "three drugs and three prescriptions" included in the national new crown diagnosis and treatment plan, and Beijing's hospital preparations and prevention Prescriptions and so on.
Ding Yongling, deputy general manager of Beijing Tongrentang (Group) Co., Ltd., China, introduced that this time, the group will bring a global coverage map of "Strengthening and Avoiding Plague Drink", medicines, four diagnostic instruments, Anniu holographic projection, herbal extraction machine, and smart medical care Other experience interaction, traditional rubbing board experience, "Overseas Epidemic Prevention and Control Manual (English Version)" book display, etc. In this year's epidemic, Tongrentang Group established an overseas Chinese medicine expert group for the prevention and treatment of new coronary pneumonia, determined a "one country (region), one policy" Chinese medicine prevention plan, and launched a series of Chinese medicine preventive prescriptions "Strengthening and avoiding plague".
Liu Xinyan, director of the International Medical Department of Guang'anmen Hospital of the Chinese Academy of Chinese Medical Sciences, introduced that in the prevention and control of the epidemic, Guang'anmen Hospital has established a joint consultation mechanism with Chinese and Western medicine participation and full collaboration. The remote consultation team composed of experts and backbones successively conducted 32 remote guidance for confirmed cases in 5 hospitals inside and outside Beijing, and achieved satisfactory results. At the same time, concentrated expert wisdom and anti-epidemic experience formulated preventive prescriptions, and provided 370,000 doses of filth-free and detoxifying Chinese medicine preparations for 25 units and departments in the city. Traditional Chinese medicine played an important role in epidemic prevention and control.
Beijing News reporter Dai Xuan